US equities |
MU $1,086.00 ▲+3.87% NVDA $237.90 ▼-0.56% SNDK $1,696.41 ▲+2.16% SPCX $167.46 ▼-2.59% AMD $647.78 ▼-0.25% TSLA $378.15 ▼-0.66% INTC $112.93 ▲+0.38% AAPL $336.55 ▲+0.88%
FinancialContent

Latest News about Avance Clinical

Recent news which mentions Avance Clinical

Incannex Receives HREC Approval For Phase 2 Clinical Trial Of CBD-Based Drug For Use In Treatment Of Rheumatoid Arthritis
Tickers IXHL
Tags Penny Stocks Market News Mark Bleackley
From Benzinga
Incannex Starts Phase 2 Clinical Trial Of CBD-Based Drug For Use In Treatment Of Rheumatoid Arthritis
Tickers IXHL
Tags Market News Penny Stocks premium
From Benzinga
Incannex Approved To Commence Phase 1 Clinical Trial Of CBD Based Anti-Inflammatory Drug
Tickers IXHL
Tags Markets CMAX Clinical Research Penny Stocks
From Benzinga